Home-based rehabilitation can be helpful for easing fatigue, improving motor and cognitive function, and life quality for people with multiple sclerosis (MS), a new clinical trial has found.
The...
MS-UK are celebrating after scooping Campaign of the Year at the Institute of Fundraising East Anglia regional awards for their My MS Marathon campaign.
More than 20 charities across the region...
A new study from Canada has found that women with multiple sclerosis (MS) and breast cancer do not have a higher risk of dying than those without the neurological condition.
They did find, though,...
The National Institute for Health and Care Excellence (NICE) has announced it does not recommend Zeposia (ozanimod) for multiple sclerosis (MS) treatment on the NHS in England and Wales.
The drug was...
Therapies for people with multiple sclerosis (MS) that deplete B-cells affect antibodies for Covid-19, a new study has found.
Most disease-modifying therapies (DMTs) for MS limit immune responses to...
MRIs in the future could be safer thanks to the granting of a US patent for radiology software which reduces the amount of contrast agent, gadolinium, needed by 90%. The software uses artificial...
A new tool to help multiple sclerosis (MS) patients choose the best treatment for them. There are currently 18 approved disease-modifying therapies available on the NHS in the UK, and a group of...
People with multiple sclerosis (MS) who experience restless leg syndrome are more likely to have greater disability and MRI lesions than those who do not, a new study has found.
The study’s...
Mindfulness can reduce depression in people with multiple sclerosis (MS), a new study has found.
The research, which took place in an outpatient clinic in Germany, found that reducing depression also...
The majority of people with multiple sclerosis (MS) who catch Covid-19 go on to experience worsening of current symptoms, or new symptoms, a new survey has found.
The UK MS Register Covid-19 study...
